期刊文献+

3组常用一线抗HIV药物疗效观察 被引量:3

Study of curative effect accuracy among 3 groups of commonly used anti-HIV drugs
暂未订购
导出
摘要 目的通过动态临床试验分析,对广西地区目前常用的AZT、d4T及TDF为主的3组抗反转录病毒治疗方案进行临床疗效比较。方法收治HIV/AIDS患者76例,分为3组,AZT组接受AZT+3TC+EFV治疗,d4T组接受d4T+3TC+EFV治疗,TDF组接受TDF+3TC+EFV治疗。对3组30个月内新发机会性感染率、免疫重建效果、病毒学应答效果、主要生化指标变化、换药及耐药情况进行动态分析比较。结果 3组患者经治疗满6个月时HIV RNA载量显著下降(P均<0.05),CD4+T淋巴细胞计数显著上升(P均<0.05),但是3组间差异无统计学意义;6个月以后各组CD4+T淋巴细胞计数上升缓慢,12个月和18个月时,d4T组CD4+T淋巴细胞计数上升幅度均大于AZT组和TDF组(P均<0.05);3组患者治疗满6个月ALB显著升高(P均<0.05),而后各阶段变化不大;AZT组、d4T组、TDF组随访期间新发机会性感染发生率分别为15.62%、11.53%、27.77%,不良反应换药率分别为12.50%、30.80%、16.67%,但差异均无统计学意义。结论广西地区3组常用一线抗HIV药物方案的治疗效果显著且相似,但d4T方案因药物不良反应和耐药而换药的发生率较高,应考虑停用。 Objective To compare clinical curative effect of 3 ART regimens in Guangxi region through a dynamic clinical trial analysis. Methods Seventy-six HIV/AIDS patients were included in this study and randomly divided into 3 groups. AZT group was treated with AZT+3TC+EFV. The d4T group received d4T+3TC+EFV treatment. TDF group received TDF+3TC+EFV treatment. The incidence of opportunistic infections, immune reconstitution, virological response, changes of major biochemical indexes, dressing change and drug resistance were dynamically analyzed and compared in 3 groups within 30 months. Results The HIV-RNA loading was significantly decreased in 3 groups at 6 months of treatment (P 〈 0.05), while the levels of CD4~ T lymphocytes increased significantly (P 〈 0.05), but there was no significant difference among 3 groups. After 6 months of treatment, CD4+ T lymphocytes increased gradually in 3 groups. At 12 and 18 months, the increment of CD4+ T lymphocytes in d4T group was more significant than that in AZT group and TDF group (P 〈 0.05). The ALB level in 3 groups increased significantly at 6 months of treatment (P 〈 0.05), and then the change was not obvious at subsequent time points. The incidence of opportunistic infections was 15.62% in AZT group, 11.53% in d4T group, 27.77% in TDF group. The dressing change rate was 12.50% in AZT group, 30.80% in d4T group and 16.67% in TDF group, respectively, however no significant difference was observed. Conclusions Three first-line anti-HIV drug regimens commonly used in Guangxi area have significant and similar effects, but the rate of dressing change for d4T regimen is higher due to adverse drug reactions and drug resistance, so this regimen is recommended to withdraw.
出处 《传染病信息》 2017年第6期342-345,383,共5页 Infectious Disease Information
基金 南宁市兴宁区科学研究与技术开发项目(2015A15) 十三五国家重大新药创制课题(2017ZX09009070-001-008)
关键词 HIV/AIDS患者 齐多夫定 司他夫定 替诺福韦 疗效 HIV/AIDS patients zidovudine stavudine tenofovir curative effect
  • 相关文献

参考文献6

二级参考文献97

  • 1韩晓旭,张旻,崔为国,刘宝贵,王亚男,张子宁,刘静,耿文清,刁莹莹,代娣,姜拥军,尚红.我国部分地区抗HIV治疗效果实验室评估和耐药变异的初步研究[J].中华医学杂志,2005,85(11):760-764. 被引量:10
  • 2潘光合,胡慧宁,黄彩凤,陆秋妮.HIV感染者中乙型肝炎病毒感染及其免疫水平分析[J].中国艾滋病性病,2006,12(2):111-112. 被引量:5
  • 3艾滋病诊疗指南[J].中国感染与化疗杂志,2006,6(4):265-279. 被引量:42
  • 4Maria Au,Jessica Haberer.Overview of HIV drug resistance and its implications for China[J].Chinese Medical Journal,2006(23):1999-2004. 被引量:15
  • 5Dabis F,Newell ML,Hirschel B.HIV drugs for treatment,and for prevention[J].Lancet,2010,375(9731):2056-2057.
  • 6Piacenti FJ.An update and review of antiretroviral therapy[J].Pharmacotherapy,2006,26(8):1111-1133.
  • 7Sluis-Cremer N,Temiz NA,Bahar I.Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding[J].Curr HIV Res,2004,2(4):323-332.
  • 8Kim RJ,Wilson CG,Wabitsch M,et al.HIV protease inhibitorspecific alterations in human adipocyte differentiation and metabolism[J].Obesity (Silver Spring),2006,14(6):994-1002.
  • 9Santhanam H,Goins M.Antiretroviral update:recent advances expand options for patients with HIV[J].Adv Nurse Pract,2004,12(11):53-54,56.
  • 10de Mendoza C,Valer L,Ribera E,et al.Performance of six different ritonavir-boosted protease inhibitor-based regimens in heavily antiretroviral-experienced HIV-infected patients[J].HIV Clin Trials,2006,7(4):163-171.

共引文献323

同被引文献18

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部